CD8A and type 1 diabetes mellitus: The divergent inhibitory phenotypes of these cells, including iNKR expression by the CD57+ T cells, point to a possible role for multiple inhibitory systems driving effector CD8+ T cells toward an inhibited or exhausted state that could be beneficial in the context of T1D and other autoimmune diseases.